Your session is about to expire
← Back to Search
Zolpidem Pharmacokinetics in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Study Summary
This trial will study how the drug zolpidem affects women and men differently. Men with prostate cancer and women will take the drug and researchers will measure how much of the drug is in their system.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I haven't had any other cancers except for non-dangerous skin cancer or very early stage leukemia in the last 2 years.I am a healthy woman over 18, can take pills, and agree to not breastfeed for 24 hours after taking zolpidem.I do not have any serious illnesses that would stop me from following the study's requirements.I do not have severe heart problems or recent heart attacks.I have no liver, stomach, or other conditions affecting medication processing.I am not on medications that affect zolpidem metabolism.I am a man with confirmed or clinically consistent prostate cancer.I am not on HIV drugs due to potential drug interactions.I am a man aged 18 or older.I am fully active or can carry out light work.My prostate cancer is getting worse, shown by rising PSA levels or scans.I have not received chemotherapy for prostate cancer.I can swallow pills.The study is only open to people of Asian descent.I am a man who hasn't taken any experimental drugs or herbal meds recently.You are currently taking other sleeping pills or have a history of mental health problems.I am at risk of falling or have recently had a fracture.You are allergic or have had a bad reaction to zolpidem or similar drugs.I am currently being treated for Hepatitis B or C.My blood tests show normal organ function and healthy blood cell counts.I am planning to undergo hormone therapy for my cancer.
- Group 1: Female
- Group 2: Zolpidem pre and post castration
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you provide me with a summary of past research regarding Zolpidem?
"Presently, 7 clinical trials are studying Zolpidem with none of them being in Phase 3. While most studies take place at Silver Spring, Maryland, 16 other sites across the United States are also conducting research on this medication."
Is Zolpidem a viable option for individuals seeking safer treatment?
"The safety of Zolpidem was appraised as a 1 due to the Phase 1 trial status; there is only minimal data currently available on its efficacy and security."
How many participants are included in this research endeavor?
"Affirmative. Clinicaltrials.gov highlights that this medical experiment is actively recruiting participants, having first been posted on January 22nd 2019 and most recently updated on November 22nd 2022. This trial necessitates the recruitment of 30 individuals from a singular site."
Is enrollment for this clinical trial available at this time?
"Information on clinicaltrials.gov indicates that this medical research is actively recruiting individuals for evaluation. This trial was initially made available to the public in January of 2019, with its most recent update taking place in November of 2022."
Share this study with friends
Copy Link
Messenger